✦ LIBER ✦

Sulfasalazine in psoriatic arthritis: A new or established indication?

✍ Scribed by P. Goupille; J. P. Valat

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 222 KB
Volume: 39
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780390431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxic epidermal necrolysis after sulfasa

Toxic epidermal necrolysis after sulfasalazine treatment of mild psoriatic arthritis: Warning on the use of sulfasalazine for a new indication

✍ D. Jullien; P. Wolkenstein; E. Roupie; J. C. Roujeau; J. Revuz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

A modified sharp score demonstrates dise

A modified sharp score demonstrates disease progression in established psoriatic arthritis

✍ J. Ravindran; C. Cavill; C. Balakrishnan; S. M. Jones; E. Korendowych; N. J. McH 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 73 KB 👁 1 views

Endothelial dysfunction in psoriatic art

Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

✍ Gonzalez-Juanatey, Carlos ;Llorca, Javier ;Miranda-Filloy, Jose A. ;Amigo-Diaz, 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Abstract ## Objective To determine whether endothelial dysfunction was present in a cohort of patients with psoriatic arthritis (PsA) without overt cardiovascular disease or classic cardiovascular risk factors attended to in a community hospital. ## Methods Fifty patients with PsA who fulfill

Add-on or step-up trials for new drug de

Add-on or step-up trials for new drug development in rheumatoid arthritis: A new standard?

✍ Maarten Boers 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 1 views

High prevalence of subclinical atheroscl

High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

✍ Gonzalez-juanatey, Carlos ;Llorca, Javier ;Amigo-Diaz, Encarnacion ;Dierssen, Tr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Golimumab, a new human tumor necrosis fa

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four–week efficacy and safety results of a randomized, placebo-controlled study

✍ Arthur Kavanaugh; Iain McInnes; Philip Mease; Gerald G. Krueger; Dafna Gladman; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views